Neuphoria Therapeutics Inc. (NEUP)

Latest Insider Confidence Score

2026Q1

59.0
Bullish

Company insider confidence (by quarter)

2024Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Papapetropoulos Spyros 5,999,940 Jul 8, 2024
Nichols Weston 10% Owner 875,328 Oct 23, 2025
Lynx1 Capital Management LP 10% Owner 875,328 Oct 23, 2025
Ryan Jane 500,000 Jul 8, 2024
Davies Peter Miles Winston 269,984 Jul 12, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 20, 2026 Jan 21, 2026 Wilson David Ian Director Neutral 52.5 - 0.00% -
Jan 20, 2026 Jan 21, 2026 Davies Peter Miles Winston Director Neutral 52.5 - 0.00% -
Jan 20, 2026 Jan 21, 2026 Fisher Alan Director Neutral 52.5 - 0.00% -
Jan 20, 2026 Jan 21, 2026 Ryan Jane Director Neutral 52.5 - 0.00% -
Oct 21, 2025 Oct 23, 2025 Lynx1 Capital Management LP 10% Owner Buy 100.0 +639,110 270.56% $3.3M
Oct 23, 2025 Lynx1 Capital Management LP 10% Owner Neutral 52.5 - 0.00% -
Aug 27, 2025 Sep 2, 2025 Papapetropoulos Spyros CEO Neutral 52.5 - 0.00% -
Apr 16, 2025 May 19, 2025 Papapetropoulos Spyros CEO Neutral 52.5 - 0.00% -
Apr 16, 2025 Apr 18, 2025 Papapetropoulos Spyros CEO Neutral 52.5 - 0.00% -
Apr 16, 2025 Apr 18, 2025 Davies Peter Miles Winston Director Neutral 52.5 - 0.00% -
Apr 16, 2025 Apr 18, 2025 Ryan Jane Director Neutral 52.5 - 0.00% -
Apr 16, 2025 Apr 18, 2025 Wilson David Ian Director Neutral 52.5 - 0.00% -
Apr 16, 2025 Apr 18, 2025 Fisher Alan Director Neutral 52.5 - 0.00% -
Jul 12, 2024 Davies Peter Miles Winston Director Neutral 52.5 - 0.00% -
Jul 8, 2024 Cunningham Timothy M. CFO Neutral 52.5 - 0.00% -
Jul 8, 2024 Ryan Jane Director Neutral 52.5 - 0.00% -
Jul 8, 2024 Wilson David Ian Director Neutral 52.5 - 0.00% -
Jul 8, 2024 Fisher Alan Director Neutral 52.5 - 0.00% -
Jul 8, 2024 Weaver Aaron Ngoc Dung Director Neutral 52.5 - 0.00% -
Jul 8, 2024 Papapetropoulos Spyros CEO Neutral 52.5 - 0.00% -